Automatically Signal-Enhanced Lateral Flow Immunoassay for Ultrasensitive Salivary Cortisol Detection
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 2, 2025
Competitive
lateral
flow
immunoassay
(LFI)
is
a
commonly
used
platform
for
detecting
cortisol
and
other
small
molecules.
However,
its
low
sensitivity
critical
limitation
application
in
point-of-care
tests.
Thus,
various
signal
enhancement
methods
have
been
developed,
requiring
complex
operational
steps
specialized
detectors.
In
this
study,
we
propose
an
automatic
signal-enhanced
LFI
(asLFI),
providing
100
times
improved
colorimetric
by
applying
10,000-fold
fewer
AuNP
conjugates
compared
to
conventional
competitive
LFI,
involving
single
step.
The
incorporation
of
improves
the
but
does
not
produce
visible
spontaneously.
asLFI
facilitates
without
additional
steps,
affording
signals.
demonstrated
high
(limit
detection
=
3.8
pg
mL-1)
across
range
0.01-10
ng
mL-1
with
linearity
correlation
(R2
0.9159).
Furthermore,
strong
ELISA
was
observed,
validating
performance
sensor
18
human
saliva
samples
0.9763).
This
novel
offers
simple
operation,
ultrasensitive
tests
circadian
monitoring
cortisol.
Language: Английский
Ferulic acid protects against stress-induced myocardial injury in mice
Siyong Li,
No information about this author
Peiyi He,
No information about this author
Jiahe Liu
No information about this author
et al.
Toxicology and Applied Pharmacology,
Journal Year:
2025,
Volume and Issue:
498, P. 117309 - 117309
Published: March 20, 2025
Language: Английский
A randomised controlled trial assessing the effects of weather sensitivity profile and walking in nature on the psychophysiological response to stress in individuals with coronary artery disease. A study protocol
BMC Psychology,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: Feb. 19, 2024
The
following
protocol
pertains
to
a
pioneer
study,
aiming
investigate
how
weather
sensitivity
and
walking
in
different
environments
affects
the
psychophysiological
responses
stress
of
individuals
with
coronary
artery
disease
(CAD)
during
rehabilitation
(WE_SENSE_THE_NATURE).
This
randomised
control
trial
will
provide
fresh
insight
on
influence
environmental
exposure
CAD
patients,
as
it
is
seldom
investigated
association
disease.
Additionally,
findings
link
between
personality
traits
cognitive
functions
(especially
flexibility),
may
help
reveal
fine-grained
perspective
treatment
possibilities
for
at
risk
stress-vulnerability.
proposed
among
attending
cardiac
program.
We
aim
recruit
164
individuals,
collecting
information
related
demographic
characteristics,
sensitivity,
functional
capacity,
traits,
subjective
mental
health
status,
function,
basal
cortisol
level
participating
individuals.
Basal
refers
concentration
saliva
be
tested
morning
afternoon
prior
day
experiment.
After
baseline
measurements,
patients
randomly
assigned
either
outdoors
or
indoors.
All
measures
their
sequential
order
remain
same
within
each
group,
while
condition
(i.e.,
environment)
vary
groups.
On
experiment,
hemodynamic
parameters
(assessed
via
6-hour
blood
pressure
measurements),
(consisting
assessments
level),
mood
using
visual
analogues
scale)
registered.
Cold
test
administered
evaluate
effect
environments.
outcomes
this
study
have
direct
clinical
applications
use
types
exercise
programs.
Awareness
about
potential
reactions
contribute
timely
planning
implementation
actions
leading
improved
medical
care
services
preventive
measures,
especially
considering
expected
oscillations
extreme
events
due
unfolding
climate
change.
has
been
retrospectively
registered
ClinicalTrials.gov
identifier
code:
NCT06139705
November
20,
2023.
Language: Английский
Relationship between subjective and objective fatigue and sleep characteristics in individuals with anxiety and mood disorders: An exploratory study
Physiology & Behavior,
Journal Year:
2023,
Volume and Issue:
274, P. 114429 - 114429
Published: Dec. 6, 2023
Language: Английский
A Novel Cortisol Immunosensor Based on a Hafnium Oxide/Silicon Structure for Heart Failure Diagnosis
Hamdi Ben Halima,
No information about this author
Nadia Zine,
No information about this author
J. Bausells
No information about this author
et al.
Micromachines,
Journal Year:
2022,
Volume and Issue:
13(12), P. 2235 - 2235
Published: Dec. 16, 2022
Assessing
cortisol
levels
in
human
bodies
has
become
essential
to
diagnose
heart
failure
(HF).
In
this
work,
we
propose
a
salivary
detection
strategy
as
part
of
an
easily
integrable
lab-on-a-chip
for
HF
biomarkers.
Our
developed
capacitive
immunosensor
based
on
hafnium
oxide
(HfO2)/silicon
structure
showed
good
linearity
between
increasing
concentration
and
the
charge-transfer
resistance/capacitance.
Moreover,
biosensor
was
demonstrated
be
highly
selective
toward
compared
other
biomarkers
such
tumor
necrosis
factor
(TNF-α)
N-terminal
pro-brain
natriuretic
peptide
(NT-proBNP).
The
precision
our
evaluated,
difference
determined
saliva
its
expected
one
is
<18%.
Language: Английский
One-Drop Enhancement Trap Lateral Flow Immunoassay for Detection of Salivary Cortisol
Published: Jan. 1, 2024
Download
This
Paper
Open
PDF
in
Browser
Add
to
My
Library
Share:
Permalink
Using
these
links
will
ensure
access
this
page
indefinitely
Copy
URL
DOI
Language: Английский
Automatically Signal-Enhanced Lateral Flow Immunoassay for Ultra-Sensitive Detection of Salivary Cortisol
Published: Jan. 1, 2024
Language: Английский
The risk of coronary artery disease in patients with type 2 diabetes mellitus and metabolic syndrome
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine),
Journal Year:
2024,
Volume and Issue:
20(4), P. 278 - 285
Published: Aug. 2, 2024
Background.
The
relevance
of
this
work
is
due
to
the
growing
need
for
a
personalized
approach
management
patients
with
coronary
artery
disease
(CAD)
and
type
2
diabetes
mellitus
(T2DM)
that
arose
on
background
metabolic
syndrome
(MS)
determining
individual
risk
each
patient.
purpose
study
was
find
out
methodology
complications
in
patient
using
lipid,
carbohydrate
hormonal
parameters.
Materials
methods.
A
319
MS
conducted.
Six
clinical
groups
were
formed.
first
group
included
82
MS,
second
—
39
T2DM
(compensation
state)
third
35
(decompensation
fourth
44
CAD
fifth
sixth
75
MS.
control
consisted
40
healthy
individuals.
Women
accounted
69.9
%
all
men
30.1
%.
(with/without
T2DM)
calculated
above
indicators
further
construction
prognostic
probability
model.
Results.
Patients
had
pronounced
changes
metabolism
presence
decompensation.
Changes
lipid
among
(state
decompensation)
turned
be
non-specific.
Interrelated
thyroid-stimulating
hormone,
cortisol,
prolactin,
insulin
revealed
depending
form
severity
syntropic
pathology.
Given
parameters,
model
diabetes)
calculated.
Fifteen
factors
selected,
which,
according
our
own
observations,
could
influence
development
At
same
time,
10
identified
reliable
CAD.
preventive
nature
high-density
lipoprotein
cholesterol
prolactin
(in
women)
effect
occurrence
provoking
diabetes,
age,
triglyceride,
cortisol
levels,
body
mass
index,
glycated
hemoglobin
revealed.
Their
regression
coefficients
determined,
reliability
checked
Wald
method,
whole
chi-square,
accuracy
79.4
%,
specificity
77.3
sensitivity
81.9
Conclusions.
an
increase
level
HOMA-IR,
shift
spectrum;
women,
hormone
against
normal
values
free
thyroxine.
Decompensation
accompanied
by
at
levels
contrast
state
compensation,
women
significantly
increased,
regardless
compensation.
method
calculating
anthropometric
indicators,
spectrum,
proposed.
Language: Английский
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON STANDARDIZED FENUGREEK SEED EXTRACT COMPOSITION FOR ENDURANCE ENHANCEMENT IN RECREATIONALLY ACTIVE YOUNG SUBJECTS
Asian Journal of Pharmaceutical and Clinical Research,
Journal Year:
2024,
Volume and Issue:
unknown, P. 155 - 165
Published: Dec. 7, 2024
Objective:
To
evaluate
the
efficacy
and
safety
of
8-week
supplementation
with
FEΔE
(fenugreek
seed
extracts
composition,
standardized
to
4-hydroxyisolecuine,
trigonelline,
select
glycosides)
on
endurance
capacity
in
recreationally
active
young
male
subjects,
a
randomized,
double-blind,
Placebo-controlled
manner.
Methods:
The
153
participants
were
randomized
equally
into
three
groups
received
either
300
mg
or
600
FeΔE
capsules
matching
Placebo.
Each
participant
performed
exercise
training
four
times
per
week
visited
study
center
day
recruitment
(baseline)
end
week-4,
week-8.
outcome
measures
(overall,
cardiovascular,
respiratory,
metabolic),
power,
work,
physical
central
fatigue,
stress,
whereas
outcomes
adverse
events
monitoring,
compliance,
biochemical
laboratory
measurements.
Results:
(but
not
Placebo)
showed
statistically
significant
beneficial
changes
overall
(increased
time
exhaustion
total
distance
run),
respiratory
oxygen
consumption),
metabolic
equivalent
decreased
non-esterified
fatty
acids
levels),
fatigue
(decreased
Wingate
index),
(reduced
visual
analog
score),
mental
domain
score
Multidimensional
Fatigue
Symptom
Inventory-Short
Form)
during
within
group
(vs.
baseline)
comparisons.
did
differ
between
(FEΔE
vs.
Placebo).
Conclusion:
Eight
weeks
resulted
comprehensive
enhancement,
including
metabolic,
endurance.
was
found
be
safe
without
serious
events.
Language: Английский